Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial

首圖 「EFFISAYIL™ 2 is the first and largest multinational randomized clinical trial to evaluate a treatment for the prevention of GPP flares,」 said Bruce Strober, MD, PhD, Clinical Professor, Dermat…


發佈留言